Shah, M. J., Noronha, V., Menon, N. S., Patil, V. M., Kapoor, A., Dhar, A., Goud, S., Agrawal, A., Sable, N., Chavan, N., Pradosh, A., Gota, V., Prabhash, K. (2025). Lower-dose versus standard-dose abiraterone in patients with metastatic castration resistant prostate cancer: A multicentric randomized phase III non-inferiority trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba5078